Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modelling and simulation in clinical drug development.

K F. Rooney1, E Snoeck, P H. Watson

  • 1Pharsight Corporation, Argentum Centre, 2 Queen Caroline Street, W6 9DT, London, UK

Drug Discovery Today
|July 27, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magnetic vortex nucleation and annihilation in bi-stable ultra-small ferromagnetic particles.

Nanoscale·2020
Same author

Local deformation gradients in epitaxial Pb(Zr<sub>0.2</sub>Ti<sub>0.8</sub>)O<sub>3</sub> layers investigated by transmission electron microscopy.

Journal of physics. Condensed matter : an Institute of Physics journal·2018
Same author

Optimising electron microscopy experiment through electron optics simulation.

Ultramicroscopy·2017
Same author

HRTEM Studies of Stress Assisted Sintered BaLa4Ti4O15.

Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada·2015
Same author

Development of TEM and SEM high brightness electron guns using cold-field emission from a carbon nanotip.

Ultramicroscopy·2014
Same author

Knowledge and attitude of the Flemish primary care physician toward organ donation and transplantation.

Transplantation proceedings·2014
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
Same journal

Chemical intervention strategies targeting MYC for cancer therapy.

Drug discovery today·2026
See all related articles

Pharmaceutical companies are enhancing research and development (R&D) by utilizing modeling and simulation. These technologies streamline clinical drug development, saving time and money while ensuring optimal drug quality.

Area of Science:

  • Pharmacology
  • Drug Development
  • Computational Science

Background:

  • Increasing pressure on pharmaceutical companies to improve R&D efficiency.
  • Need for technologies to accelerate product flow through the development pipeline.

Purpose of the Study:

  • To describe the application of modeling and simulation in improving clinical drug development.
  • To highlight the benefits of these methodologies in saving time and resources.

Main Methods:

  • Utilizing twin processes of modeling and simulation.
  • Applying these techniques to the clinical drug-development process.

Main Results:

  • Significant improvements in the efficiency of clinical drug development.

Related Experiment Videos

  • Demonstrated benefits in saving time and reducing costs.
  • Assisted in ensuring optimal quality for drug labels.

    • Conclusions:

    • Modeling and simulation are effective tools for optimizing the drug development pipeline.
    • These methodologies offer substantial advantages in bringing novel therapeutic agents to market efficiently.